Octapharma

Octapharma, founded in 1983, is a chemical manufacturing company based in Los Angeles, California, Switzerland, with 2234 employees. Specializing in plasma Fractionation, Haematology, Immunotherapy, and Critical Care, the company has a revenue of $114 million. Octapharma's focus on plasma products has helped him lead an active life and has been recognized as a sponsor of WFH 2022 World Congress. The company has a strong growth in sales and operating income, and it has contributed to the growth of sales and operating income in 2021.

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs more than 11,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology, and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centres across Europe and the US. Check our community guidelines: https://bit.ly/3M8ioml

Social

Endo International plc is a global specialty pharmaceutical company that offers high-value branded pharmaceutical products, treatments for unmet pelvic health needs, affordable, high-quality generic pharmaceuticals, and pharmaceutical products for Canadian and emerging markets. They also provide research and development capabilities, patient safety, clinical research, and postmarketing commitments